Skip to main content
. 2022 Dec 7;13:1011700. doi: 10.3389/fimmu.2022.1011700

Table 2.

Haplotype analysis of WNT pathway genes in PTB patients and controls.

Haplotype PTB [n(%)] Controls [n(%)] P value OR (95% CI)
SFRP1 rs10088390-rs4736958-rs3242
CTA 26.95 (3.0) 34.30 (3.70) 0.415 0.808(0.484, 1.350)
CTG 516.44 (57.1) 535.24 (57.6) 0.991 0.999(0.827, 1.207)
GCG 285.30 (31.6) 293.36 (31.5) 0.913 1.011(0.829, 1.233)
GTG 46.66 (5.2) 43.93 (4.7) 0.641 1.106(0.724, 1.688)
WNT3A rs752107-rs3121310
CA 142.00 (15.7) 128.35 (13.8) 0.259 1.161(0.896, 1.503)
CG 545.00 (60.3) 567.65 (61.0) 0.692 0.963(0.798, 1.161)
TA 217.00 (24.0) 231.65 (24.9) 0.630 0.949(0.767, 1.174)
CTNNB1 rs2293303-rs1798802-rs4135385
CAA 158.80 (17.6) 161.35 (17.3) 0.889 1.017(0.799, 1.295)
CGA 154.24 (17.1) 157.96 (17.0) 0.951 1.008(0.790, 1.286)
CGG 453.23 (50.1) 495.57 (53.3) 0.188 0.884(0.735, 1.062)
TAA 130.44 (14.4) 109.22 (11.7) 0.085 1.270(0.967, 1.668)
WIF-1 rs1026024-rs3782499
AT 158.96 (17.6) 183.03 (19.8) 0.228 0.865(0.684, 1.095)
GC 165.96 (18.4) 163.93 (18.2) 0.914 1.013(0.799, 1.284)
GT 579.04 (64.1) 577.07 (6.21) 0.375 1.090(0.901, 1.317)
DKK-1 rs2241529-rs1569198
AA 600.60966.4) 626.80 (67.4) 0.692 0.961(0.791, 1.169)
GA 104.40 (11.5) 77.20 (8.3) 0.019 1.445(1.060, 1.969)
GG 195.59(21.6) 223.80 (24.1) 0.221 0.873(0.701, 1.086)
LRP5 rs3736228-rs556442
CA 667.84 (73.9) 660.92 (71.1) 0.164 1.157(0.942, 1.442)
CG 68.16 (7.5) 69.08 (7.4) 0.921 1.018(0.719, 1.441)
TG 165.84 (18.3) 198.92 (21.4) 0.105 0.827(0.657, 1.041)
LRP6 rs2302685-rs11054697-rs10743980
CTT 56.70 (1.4) 56.32 (6.1) 0.860 1.035(0.707, 1.515)
TCT 68.59 (7.6) 85.76 (9.2) 0.200 0.805(0.578, 1.122)
TTC 669.13 (7.4) 673.08 (72.4) 0.476 1.081(0.873, 1.337)
TTT 91.83 (10.2) 93.92 (10.2) 0.983 1.003(0.740, 1.359)

Frequency < 0.03 in both controls & PTB patients has been dropped.

Bold value means P < 0.05.